HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katherine A Janeway Selected Research

Pneumothorax

12/2023Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katherine A Janeway Research Topics

Disease

53Neoplasms (Cancer)
12/2023 - 07/2009
24Osteosarcoma (Osteogenic Sarcoma)
12/2023 - 07/2010
12Ewing Sarcoma (Sarcoma, Ewing)
12/2023 - 01/2017
8Sarcoma (Soft Tissue Sarcoma)
04/2024 - 11/2012
8Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2020 - 10/2007
4Neoplasm Metastasis (Metastasis)
11/2020 - 08/2014
3Disease Progression
11/2023 - 01/2019
3Carcinoma (Carcinomatosis)
01/2022 - 04/2011
3Paraganglioma (Paragangliomas)
11/2021 - 01/2011
2Brain Neoplasms (Brain Tumor)
11/2023 - 07/2017
2Lymphoma (Lymphomas)
11/2023 - 10/2022
2Glioma (Gliomas)
10/2022 - 06/2013
2Fibrosarcoma
08/2022 - 01/2018
2Aggressive Fibromatosis (Desmoid)
10/2020 - 07/2017
2Left Ventricular Dysfunction
01/2019 - 10/2016
1Pneumothorax
12/2023
1Myofibromatosis
01/2023
1Long Term Adverse Effects
12/2022
1Plexiform Neurofibroma
10/2022
1Sudden Death
09/2022
1Soft Tissue Neoplasms
08/2022
1Glomus Tumor (Glomus Tumors)
01/2022
1Hypoxia (Hypoxemia)
11/2021
1Hypertension (High Blood Pressure)
11/2021
1Headache (Headaches)
11/2021
1Polycythemia (Erythrocytosis)
11/2021
1Leukemia
01/2021
1Adenocarcinoma
01/2021
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
10/2020
1Desmoplastic Small Round Cell Tumor
10/2020
1Myofibroma
04/2020
1Medullary Carcinoma
12/2019

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2013
7Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2011
7RNA (Ribonucleic Acid)IBA
01/2022 - 12/2014
4Succinate Dehydrogenase (Fumarate Reductase)IBA
07/2016 - 01/2011
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2024 - 12/2021
3Methotrexate (Mexate)FDA LinkGeneric
06/2023 - 07/2010
3Phosphotransferases (Kinase)IBA
01/2023 - 06/2013
3DNA (Deoxyribonucleic Acid)IBA
11/2022 - 01/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 07/2010
2Topotecan (Hycamtin)FDA LinkGeneric
12/2023 - 12/2021
2Insulin (Novolin)FDA Link
10/2023 - 01/2016
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2023 - 04/2020
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2022 - 01/2016
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2022 - 01/2013
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2022 - 10/2020
2Vincristine (Oncovin)FDA LinkGeneric
12/2021 - 10/2020
2NucleotidesIBA
01/2021 - 07/2017
2Immune Checkpoint InhibitorsIBA
11/2020 - 01/2020
2Transcription Factors (Transcription Factor)IBA
03/2019 - 01/2017
2Sunitinib (Sutent)FDA Link
01/2019 - 07/2009
2Imatinib Mesylate (Gleevec)FDA Link
01/2019 - 07/2009
2Cisplatin (Platino)FDA LinkGeneric
10/2016 - 07/2010
2Etoposide (VP 16)FDA LinkGeneric
10/2016 - 07/2010
2IfosfamideFDA LinkGeneric
10/2016 - 07/2010
2TOR Serine-Threonine KinasesIBA
01/2016 - 12/2014
2MicroRNAs (MicroRNA)IBA
01/2013 - 01/2013
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2009 - 10/2007
1fludarabineIBA
04/2024
1Chimeric Antigen ReceptorsIBA
04/2024
1cabozantinibIBA
12/2023
1tazemetostatIBA
11/2023
1Tyrosine Kinase InhibitorsIBA
11/2023
1ganitumabIBA
10/2023
1Monoclonal AntibodiesIBA
10/2023
1Circulating Tumor DNAIBA
01/2023
1Mitogen-Activated Protein KinasesIBA
10/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2022
1AZD 6244IBA
10/2022
1dinutuximabIBA
09/2022
1CytokinesIBA
09/2022
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2022
1tyrosine receptor (receptor, tyrosine)IBA
08/2022
1ran-binding protein 2IBA
08/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Carrier Proteins (Binding Protein)IBA
01/2022
1morinIBA
11/2021
1belzutifanIBA
11/2021
1Investigational DrugsIBA
04/2021
1ElementsIBA
01/2021
1Genetic Markers (Genetic Marker)IBA
01/2021
1LigandsIBA
11/2020
1nirogacestatIBA
10/2020
1Irinotecan (Camptosar)FDA LinkGeneric
10/2020
1Temozolomide (Temodar)FDA LinkGeneric
10/2020
13- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
01/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2019
1Ubiquitin-Conjugating EnzymesIBA
12/2019
1Proteasome InhibitorsIBA
12/2019
1glembatumumab vedotinIBA
11/2019

Therapy/Procedure

34Therapeutics
12/2023 - 07/2010
10Drug Therapy (Chemotherapy)
10/2023 - 07/2010
4Precision Medicine
01/2021 - 05/2016
2Radiotherapy
01/2023 - 11/2020
2Neoadjuvant Therapy
01/2018 - 02/2012
1Molecular Targeted Therapy
10/2022
1Investigational Therapies (Experimental Therapy)
04/2021
1Immunotherapy
11/2020
1Combined Modality Therapy
10/2020